Feedback / Questions
HER2-Specific CAR T - Cellevolve Bio, Seattle Children’s Therapeutics
http://clinicaltrials.gov/ct2/show/NCT03500991
Dec 11, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next